Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization.
Heerlein K, De Giorgi S, Degraeve G, Frodl T, Hagedoorn W, Oliveira-Maia AJ, Otte C, Perez Sola V, Rathod S, Rosso G, Sierra P, Vita A, Morrens J, Rive B, Mulhern Haughey S, Kambarov Y, Young AH. Heerlein K, et al. Among authors: morrens j. J Affect Disord. 2022 Feb 1;298(Pt A):442-450. doi: 10.1016/j.jad.2021.11.004. Epub 2021 Nov 4. J Affect Disord. 2022. PMID: 34742998 Free article.
Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study.
Oliveira-Maia AJ, Rive B, Morrens J, Godinov Y, Cabrieto J, Perualila N, Mulhern-Haughey S. Oliveira-Maia AJ, et al. Among authors: morrens j. Front Psychiatry. 2023 Oct 31;14:1250987. doi: 10.3389/fpsyt.2023.1250987. eCollection 2023. Front Psychiatry. 2023. PMID: 38025416 Free PMC article.
ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in general psychiatry.
Oliveira-Maia AJ, Morrens J, Rive B, Godinov Y, Cabrieto J, Perualila N, Barbreau S, Mulhern-Haughey S. Oliveira-Maia AJ, et al. Among authors: morrens j. Front Psychiatry. 2023 Oct 31;14:1250980. doi: 10.3389/fpsyt.2023.1250980. eCollection 2023. Front Psychiatry. 2023. PMID: 38025433 Free PMC article.
Real-world evidence from a European cohort study of patients with treatment resistant depression: Treatment patterns and clinical outcomes.
Heerlein K, Perugi G, Otte C, Frodl T, Degraeve G, Hagedoorn W, Oliveira-Maia AJ, Perez Sola V, Rathod S, Rosso G, Sierra P, Malynn S, Morrens J, Verrijcken C, Gonzalez B, Young AH. Heerlein K, et al. Among authors: morrens j. J Affect Disord. 2021 Jul 1;290:334-344. doi: 10.1016/j.jad.2021.03.073. Epub 2021 Apr 1. J Affect Disord. 2021. PMID: 34044256 Free article.
Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics.
Heerlein K, Young AH, Otte C, Frodl T, Degraeve G, Hagedoorn W, Oliveira-Maia AJ, Perez Sola V, Rathod S, Rosso G, Sierra P, Morrens J, Van Dooren G, Gali Y, Perugi G. Heerlein K, et al. Among authors: morrens j. J Affect Disord. 2021 Mar 15;283:115-122. doi: 10.1016/j.jad.2020.11.124. Epub 2020 Nov 30. J Affect Disord. 2021. PMID: 33545659 Free article.
Simultaneous Measurement of Glomerular Filtration Rate, Effective Renal Plasma Flow and Tubular Secretion in Different Poultry Species by Single Intravenous Bolus of Iohexol and Para-Aminohippuric Acid.
Stroobant L, Croubels S, Dhondt L, Millecam J, De Baere S, Gasthuys E, Morrens J, Antonissen G. Stroobant L, et al. Among authors: morrens j. Animals (Basel). 2020 Jun 12;10(6):1027. doi: 10.3390/ani10061027. Animals (Basel). 2020. PMID: 32545683 Free PMC article.
12 results